• Text Size:

  • Print:

  • Share:


Clinical Trials

Melanoma Protocols

Please check with your physician for additional protocols and/or information.

1.  S1320:  A Randomized Phase II Trial of Intermittent vs. Continuous Dosing of Dabrafenib & Trametinib in BRAF Mutant Melanoma

The purpose of this study is to compare any good and bad effects of receiving the drugs dabrafenib and trametinib continuously to receiving dabrafenib and trametinib with a break in treatment.  Dabrafenib and trametinib are similar to vemurafenib and have been tested together and found to be safe and effective for patients with advanced melanoma.  The combination has been approved by the FDA for the treatment of advanced melanoma.  This study is testing whether receiving dabrafenib and trametinib with a break in treatment could extend the time before your cancer gets worse.  It could also cause side effects. This study will allow the researchers to know whether a break in treatment is better, the same, or worse than continuous treatment of dabrafenib and trametinib. To be better, the break in treatment approach should extend the time before cancer gets worse by about 4 to 6 months compared to the continuous treatment approach.  There will be about 280 people taking part in this study

If your BRAF mutation was determined by a test that is not FDA approved, there may be a higher probability that the test was false positive, which could result in risk with no potential for benefit from dabrafenib.

For more information on these protocols or any other research, please contact your physician or our clinical research coordinator, Jessica Gerlach, CCRP at 845-333-1133.

Orange Regional
Medical Center

707 East Main Street
Middletown, NY 10940
Directions »

Orange Regional Medical
Group - Middletown

707 East Main Street
Middletown, NY 10940

Orange Regional Medical
Group - Monroe

475 Route 17M
Monroe, NY 10950

For Medical Staff
For Employees
Join Our Email List
Disclaimer | Privacy Policy | Sitemap | Locations

Copyright © 2017 Orange Regional Medical Center
Joint Commission National Quality Approved
A member of the Greater Hudson Valley Health System